Table I. Patient characteristics in the second data set.
Patient No. | Age (y)/Sex | Type | Stage | TNM Classification | Previous Treatment |
---|---|---|---|---|---|
1 | 82/M | SSM | IA | pT1aN0M0 | — |
2 | 62/F | SSM | IB | T1bN0M0 | — |
3 | 52/M | SSM | IB | T2aN0M0 | — |
4 | 59/F | SSM | IB | pT2aN0M0 | — |
5 | 63/F | ALM | IIA | pT2bN0M0 | — |
6 | 60/M | ALM | IIC | pT4bN0M0 | OP, Rec |
7 | 78/F | SSM | IIC | T4bN0M0 | — |
8 | 64/M | SSM | IIIA | pT4N2aM0 | — |
9 | 53/F | SSM | IIIA | pT2aN1aM0 | — |
10 | 54/F | SSM | IIIB | pT1bN1aM0 | OP, Rec |
11 | 63/M | NM | IIIB | pT4bN1aM0 | — |
12 | 71/F | SSM | IIIB | T1aN1bM0 | — |
13 | 33/F | ALM | IIIB | pT3bN2aM0 | — |
14 | 78/M | ALM | IIIC | pT4bN3M0 | — |
15 | 71/M | ALM | IV | T4bN3M1c | OP, CT |
16 | 62/M | MU | IV | pTxN0M1c | OP, CT |
17 | 56/F | MU | IV | pTxN0M1c | OP, CT |
18 | 39/F | SSM | IV | pTxNxM1c | OP, CT, RT |
19 | 59/F | ALM | IV | TxN3M1c | OP |
ALM, acral lentiginous melanoma; CT, chemotherapy; MU, mucosal melanoma; NM, nodular melanoma; OP, operation; Rec, recurrence; RT, radiotherapy; SSM, superficial spreading melanoma TNM, Tumor-Node-Metastasis.